Novartis India Limited (BOM:500672)
1,589.20
+2.50 (0.16%)
At close: Aug 17, 2026
Novartis India Company Description
Novartis India Limited is involved in the pharmaceutical business in India.
The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands.
It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India.
As of July 29, 2026, Novartis India Limited operates as a subsidiary of Waverise Investments Limited.
Novartis India Limited
| Country | India |
| Founded | 1947 |
| Industry | Pharmaceutical Preparations |
| Employees | 56 |
| CEO | Vikas Gupta |
Contact Details
Address: Inspire BKC Mumbai, 400051 India | |
| Phone | 91 22 50243000 |
| Website | novartis.in |
Stock Details
| Ticker Symbol | 500672 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Vikas Gupta | Chief Executive Officer |
| Shilpa Joshi | Chief Financial Officer |